PRESS RELEASE published on 10/22/2025 at 09:00, 1 year ago Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRIEF published on 10/16/2025 at 11:10, 1 year ago Andera Partners co-dirige une levée de fonds de série A de 105 millions d'euros pour Adcytherix Investissement Andera Partners Traitements Contre Le Cancer Adcytherix BioDiscovery 7
BRIEF published on 10/16/2025 at 11:10, 1 year ago Andera Partners Co-Leads €105 Million Series A for Adcytherix Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
PRESS RELEASE published on 10/16/2025 at 11:05, 1 year ago Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRIEF published on 10/15/2025 at 11:15, 1 year ago Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
BRIEF published on 10/15/2025 at 11:15, 1 year ago Andera Partners s'engage dans la série C de Tubulis, d'un montant de 308 millions d'euros, pour le développement d'ADC Andera Partners Tubulis Développement ADC Financement De Série C Expansion Clinique
PRESS RELEASE published on 10/15/2025 at 11:10, 1 year ago Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRIEF published on 06/12/2025 at 10:05, 1 year 4 months ago Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
BRIEF published on 06/12/2025 at 10:05, 1 year 4 months ago Andera Partners élargit sa stratégie de financement mezzanine sans sponsor avec des nominations clés Développement International Andera Partners Marchés Européens Nominations Stratégiques Mezzanine Sans Sponsor
PRESS RELEASE published on 06/12/2025 at 10:00, 1 year 4 months ago Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing
Published on 11/05/2026 at 15:20, 29 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 1 hour 18 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 1 hour 24 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 1 hour 29 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 1 hour 34 minutes ago Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
Published on 11/05/2026 at 15:34, 14 minutes ago Finexity AG: NuWays and GBC confirm price targets following Capital Markets Day and 9-month figures, taking the share split into account
Published on 11/05/2026 at 15:10, 38 minutes ago Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer
Published on 11/05/2026 at 14:58, 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/05/2026 at 15:01, 47 minutes ago Chiffre d'Affaires du 1er semestre de l'exercice 2026/2027
Published on 11/05/2026 at 10:16, 5 hours 32 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 10:16, 5 hours 32 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%